Sylvester Comprehensive Cancer Center


Robert Kirsner, M.D., Ph.D., and Shasa Hu, M.D.

Despite Advances, Melanoma Rates Still Vary by Race and Ethnicity


While white and Hispanic individuals are being diagnosed with melanoma more frequently in recent years, Hispanic and black patients continue to have advanced skin cancer at diagnosis, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. Those findings were made by a team of researchers from the Sylvester Comprehensive Cancer Center at the University of Miami...

Enrique A. Mesri, Ph.D.

Argentine Government Appoints Sylvester Researcher


Enrique A. Mesri, Ph.D., associate professor of microbiology and immunology at the Miller School and a member of the Viral Oncology Research Program at Sylvester Comprehensive Cancer Center, has been appointed to Argentina's Committee of Advisors for Scientific and Technological Cooperation in Foreign Countries.

Cancer Survivors Star in Spectacular Sylvester Fundraiser


Nearly 600 people filled the Moore Building in Miami’s Design District on Wednesday night, November 11, to celebrate survivorship and raise more than $250,000 for research at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. The fundraiser, “Designed For a Cure” centered around a dozen Sylvester patients escorting their doctors and nurses down the runway. As the evening wrapped up, every person was on their feet clapping and cheering the stories of survival that were highlighted during the evening.

Dean Pascal J. Goldschmidt introduces cancer survivor Steven Guarin to Eckhard Podack, M.D., Ph.D., inventor of the antibody that saved the UM student's life.

Cancer Survivor Meets Researcher Who Helped Save His Life


The thank you meeting between 21-year-old cancer survivor Steven Guarin and veteran Miller School cancer researcher Eckhard Podack, M.D., Ph.D., lasted only 30 minutes, but was nearly two decades in the making. In the early '90s, Podack, Sylvester distinguished professor and chairman of microbiology and immunology, created the antibody that is a key component of SGN-35, a potential new drug that vanquished Steven's...

UM Physician Uses Endoscopic Ultrasound to Provide Targeted Radiation Therapy


A two-year collaboration between gastroenterologists and radiation oncologists at UHealth -- University of Miami Health System has resulted in a new application of endoscopic ultrasound (EUS) that benefits prostate cancer patients. Afonso Ribeiro, M.D., associate professor of medicine in the Division of Gastroenterology, led the study which examined the feasibility and safety of using EUS to implant markers in prostate cancer patients needing targeted radiation therapy.

Sylvester Researchers Awarded Millions for Breast Cancer Study in Black Women


A team of researchers from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has been awarded a $4 million grant from the National Institutes of Health to study the effects of stress management in black women with breast cancer. The scientists want to develop innovative and effective ways to help underserved women as they navigate a difficult time in their lives.

Sylvester Researcher Expands Breakthrough Immune System Findings


A prominent researcher at the Sylvester Comprehensive Cancer Center at the Miller School, has taken another major step in understanding the mechanisms of the immune system. For the second year in a row, Glen N. Barber, Ph.D., professor of medicine and Eugenia J. Dodson Chair in Cancer Research, and Hiroki Ishikawa, Ph.D., a post-doctoral fellow, have published their findings in the prestigious journal Nature.

UM Researchers Discover Moving to the U.S. Increases Cancer Risk for Hispanics


A team of researchers at the University of Miami Miller School of Medicine has confirmed trends that different Hispanic population groups have higher incidence rates of certain cancers and worse cancer outcomes if they live in the United States than they do if they live in their homelands. Overall, the Miller School team found the cancer risk increases 40 percent or more for Hispanics in the United States.

Survival Rates from Gastrointestinal Tumors Improving Among African Americans


h4. After Years of Inequality, Survival Rates Now Equivalent to Those of Caucasians Physician-scientists at the University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center have published new research indicating that racial disparities in treating a rare gastrointestinal cancer have been greatly reduced.

Braman Institute Scientists Discover Mechanism That Promotes Cell Mobility


For some time, researchers have known that protein p27 is an important inhibitor of the cell division that spreads cancer. Understanding the full mechanism and extent of that role has taken much longer. Now, scientists at the Braman Family Breast Cancer Institute at the Sylvester Comprehensive Cancer Center have solved part of the puzzle, discovering that p27 can severely misbehave when in bad company.

UM Breast Cancer Researchers Win Department of Defense Grant to Expand Study


Breast cancer researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have been awarded a prestigious Department of Defense Synergistic Idea Award, one of just 12 such grants in the United States. The $725,000 research grant over two years will allow Lisa Baumbach, Ph.D., associate professor of pediatrics at the Miller School, and Mark Pegram, M.D., professor of medicine and associate director for clinical and translational research at the Braman Family Breast Cancer Institute at Sylvester, to expand their work examining the genetic differences found in African-American breast cancer patients.

Sylvester Hosts 10th Annual Cancer Research Competition and Lecture


The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted the tenth annual Zubrod Memorial Lecture and Cancer Research Poster Session on Friday, May 8, 2009. Bert O’Malley, M.D., professor and chairman of the Department of Molecular and Cellular Biology at Baylor College of Medicine in Houston, was this year’s guest lecturer.

Pap Corps Presents $3 Million to Fund Research at Sylvester


The 20,000 member Papanicolaou Corps for Cancer Research today announced its annual gift to fund cancer research at the Sylvester Comprehensive Cancer Center. The check for $3 million was presented to W. Jarrard Goodwin, M.D., director of Sylvester at the University of Miami Miller School of Medicine, part of the University of Miami Health System, and Sylvester Board of Governors Chair Joan Scheiner.

Sylvester First in Miami to Offer "GPS for the Body®"


Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System, today announced it is the first cancer-care program in the region enabling clinicians to accurately manage delivery of radiation to prostate cancer tumors through a new technology called the Calypso® 4D Localization System™.

UM Loses World-Renowned Researcher in Viral Cancers William J. Harrington Jr., M.D.


The University of Miami Miller School of Medicine and its Sylvester Comprehensive Cancer Center are saddened to report the untimely passing of a renowned researcher, physician, colleague and friend. William J. Harrington, Jr., M.D., professor of medicine in the Division of Hematology-Oncology at the Miller School, died from a cerebral hemorrhage on January 29 at the age of 54.

Sylvester Hosts Landon-AACR Prize Lectures; Two New Awards Given


The annual Landon-American Association for Cancer Research Prizes took a big step forward this year in recognizing key cancer research by adding two new awards. The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted the Seventh Annual Landon-AACR Prize Lectures on Friday, January 23, during which four scientists were recognized for their research.

UM Nobel Laureate Collaborates on Study of Growth Hormone-Releasing Hormone


A team of international researchers, including Nobel laureate Andrew V. Schally, Ph.D., M.D.h.c., D.Sc.h.c., distinguished professor of pathology at the University of Miami Miller School of Medicine and distinguished medical research scientist in the Department of Veterans Affairs, has uncovered a surprising new activity of growth hormone-releasing hormone (GHRH), which could redirect future studies.